Kristen Bridge

Kristen Bridge currently serves as Vice President and Head of R&D Portfolio and Business Operations at Organon since May 2021 and previously held the role of Head of R&D Strategy and Portfolio Management. Prior to Organon, Kristen Bridge was Senior Vice President of Strategy and Portfolio at Kintai Therapeutics from January 2019 to September 2020. Kristen Bridge's experience also includes roles at Bristol-Myers Squibb, where responsibilities ranged from Executive Director of Business Development Strategy and Operations to Director of Public Affairs and Investor Relations, spanning from 2005 to June 2018. Earlier career highlights include positions at Bloomberg LP, including Process Improvement Lead and Project Manager. Kristen Bridge holds an MBA from LaSalle University and dual bachelor's degrees in Management Information Systems and Services and Communication Studies from West Virginia University.